Jacob Aranda

Title: Professor Pediatrics and Director
Company: SUNY Downstate Health Sciences University
Location: New York, New York, United States

Jacob Aranda, Director of Neonatology and a Professor of Pediatrics and Ophthalmology at SUNY Downstate Health Sciences University, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in pharmacology.

A native of the Philippines, Dr. Aranda immigrated to Canada in 1969 and became a naturalized citizen in 1976. During this time, he was mentored by many brilliant minds, including Mary Ellen Avery, a recipient of presidential awards from the White House. The mental stimulation he received led to his fascination in pediatrics—specifically, infant mortality relating to drugs. Furthermore, he earned an MD from Manilla Central University in 1965 and became a diplomate of the American Board of Pediatrics in perinatal and neonatal medicine. He began his career as an intern for the United States Naval Hospital, Subic Bay, and later the Washington Hospital Center at George Washington University, from 1964 to 1966.

Moreover, Dr. Aranda completed a residency in pediatrics at the State University of New York Upstate Medical University in Syracuse for two years, and briefly joined the Case Western Reserve University School of Medicine in Cleveland, Ohio, as a fellow of neonatology from 1968 to 1969. Subsequently, he served as a research fellow of neonatology at Montreal Children’s Hospital in Quebec, Canada, between 1969 and 1971. As he advanced through his career, Dr. Aranda contributed as an attending neonatologist with the Montreal Children’s Hospital, the Royal Victoria Hospital, the Jewish General Hospital, and the Montreal General Hospital. After working as a consultant pediatrician at St. Mary’s Hospital, he joined the Montreal Children’s Hospital served as acting director of neonatal research from 1974 to 1979. During this time, he also earned a PhD in pharmacology from McGill University.

Currently, Dr. Aranda is the director of neonatology and a professor of pediatrics and ophthalmology at the State University of New York Downstate Medical Center. He has additionally contributed as the director of developmental pharmacology and perinatal research for the Montreal Children’s Hospital since 1979. In the past, he has taught pediatrics, pharmacology, and therapeutics at McGill University Medical School. An expert in the field, Dr. Aranda has co-authored five books and over 250 peer-reviewed papers and book chapters and is a member of various scientific and academic societies. Achievements to his credit include developing innovative drug therapies for newborns using drugs with a long history of use, including caffeine apnea of prematurity and intravenous ibuprofen for the closure of the patent arteriosus.

In the coming years, Dr. Aranda aims to develop medicines through the process of nano-medicine,, to prevent blindness in premature babies. He hopes to have the treatment non-perishable—something that doesn’t have to be refrigerated—and available to all, even those in third world countries. To remain aware of changes in the field, Dr. Aranda serves as chair of the National Steering Committee of the NIH Pediatric Developmental Pharmacology Research Network.

Contact Dr. Aranda:

Leave a Reply